Schneider Bipartisan Bill Passes House: COVID PREPARE Act
WASHINGTON – Today, The U.S. House of Representatives passed H.R. 7496, the COVID Preparedness, Response and Effective Planning for Advanced Requirements by the Executive Branch (PREPARE) Act. Congressmen Brad Schneider’s (IL-10) bipartisan bill passed the House in a unanimous voice vote. Republican John Katko co-led the legislation. Video of Schneider’s speech on behalf of the bill can be found here.
“With the timeline for rolling out a safe and effective vaccine still unknown, it is imperative that the government develop and implement comprehensive strategies for beating back the virus and mitigating its impact on our health care system, on our economy and on our lives and livelihoods. We can only get to the other side of these crises with clear-eyed assessment and realistic, fact-based, science-driven solutions. These are the ideas that lie behind the COVID Prepare Act. This is bipartisan, commonsense, legislation, crafted with my friend John Katko, to assure the American people that their federal government is fully prepared to address this ever-changing public health and economic crisis. We all certainly hope for the best, but we must responsibly prepare for the worst.” said Rep. Brad Schneider (IL-10).
“As Central New York’s representative in Congress, I made a solemn promise that I would hold the Administration and Federal Government accountable, and ensure we have a more effective plan for combating this crisis and a potential resurgence of the virus. The bill passed today requires the Administration and federal agencies to develop and submit plans to Congress on how our nation would respond to a ‘second wave’ of COVID-19. With Central New York continuing to face the effects of the ongoing pandemic, I will not sit idly by as the prospect of a ‘second wave’ threatens our region,” said Rep. John Katko (NY-24).
The COVID PREPARE Act would require federal agencies to submit a report to Congress on the steps they are taking to respond to a potential resurgence of COVID-19, including measurable goals, anticipated challenges, and how they will consult with Congress.